Evidence map›Paper›PMID 25662213›Full record

ArticleNucleic acids research2015

FF483-484 motif of human Polη mediates its interaction with the POLD2 subunit of Polδ and contributes to DNA damage tolerance.

Nadège Baldeck, Régine Janel-Bintz, Jérome Wagner, Agnès Tissier, Robert P Fuchs, Peter Burkovics, Lajos Haracska, Emmanuelle Despras, Marc Bichara, Bruno Chatton and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. DNA Damage Responses, the Trump Card of Stem Cells in the Survival Game.Advances in experimental medicine and biology · 2024
    Review
  3. Early embryonic lethality of mice lacking POLD2.Molecular reproduction and development · 2023
    Article
  4. Article
  5. Article
  6. Beyond the Lesion: Back to High Fidelity DNA Synthesis.Frontiers in molecular biosciences · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Translesion DNA polymerases in eukaryotes: what makes them tick?Critical reviews in biochemistry and molecular biology · 2017
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Nadège BaldeckBiotechnologie et Signalisation Cellulaire, Université de Strasbourg, UMR7242, Illkirch 67412, France.
Régine Janel-BintzBiotechnologie et Signalisation Cellulaire, Université de Strasbourg, UMR7242, Illkirch 67412, France.
Jérome WagnerBiotechnologie et Signalisation Cellulaire, Université de Strasbourg, UMR7242, Illkirch 67412, France.
Agnès TissierUMR-S1052, Inserm, Centre de Recherche en Cancérologie de Lyon, Lyon 69000, France.
Robert P FuchsCancer Research Center of Marseille (CRCM), Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7258, Marseille 13009, France.
Peter BurkovicsInstitute of Genetics, Biological Research Center, Hungarian Academy of Sciences, HU-6726 Szeged, Hungary.
Lajos HaracskaInstitute of Genetics, Biological Research Center, Hungarian Academy of Sciences, HU-6726 Szeged, Hungary.
Emmanuelle DesprasUniversité Paris-Sud, CNRS-UMR8200, Equipe labellisée Ligue Contre le Cancer, Gustave Roussy, Villejuif, France.
Marc BicharaBiotechnologie et Signalisation Cellulaire, Université de Strasbourg, UMR7242, Illkirch 67412, France.
Bruno ChattonBiotechnologie et Signalisation Cellulaire, Université de Strasbourg, UMR7242, Illkirch 67412, France.
Agnès M CordonnierBiotechnologie et Signalisation Cellulaire, Université de Strasbourg, UMR7242, Illkirch 67412, France agnes.cordonnier@unistra.fr.
Biotechnologie et Signalisation Cellulaire · FRInstitute of Genetics · HUCentre de Recherche en Cancérologie de Lyon · FRCentre de Recherche en Cancérologie de Marseille · FRInstitut Gustave Roussy · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Switching between replicative and translesion synthesis (TLS) DNA polymerases are crucial events for the completion of genomic DNA synthesis when the replication machinery encounters lesions in the DNA template. In eukaryotes, the translesional DNA polymerase η (Polη) plays a central role for accurate bypass of cyclobutane pyrimidine dimers, the predominant DNA lesions induced by ultraviolet irradiation. Polη deficiency is responsible for a variant form of the Xeroderma pigmentosum (XPV) syndrome, characterized by a predisposition to skin cancer. Here, we show that the FF483-484 amino acids in the human Polη (designated F1 motif) are necessary for the interaction of this TLS polymerase with POLD2, the B subunit of the replicative DNA polymerase δ, both in vitro and in vivo. Mutating this motif impairs Polη function in the bypass of both an N-2-acetylaminofluorene adduct and a TT-CPD lesion in cellular extracts. By complementing XPV cells with different forms of Polη, we show that the F1 motif contributes to the progression of DNA synthesis and to the cell survival after UV irradiation. We propose that the integrity of the F1 motif of Polη, necessary for the Polη/POLD2 interaction, is required for the establishment of an efficient TLS complex.

Indexed as

DNA DamageCell CycleCell LineCell SurvivalDNA-Directed DNA PolymeraseDNA Polymerase IIIHumansProtein Interaction Domains and MotifsProtein SubunitsUltraviolet RaysY-Family DNA PolymerasesDNA-Directed DNA PolymeraseDNA Polymerase IIIPOLD2 protein, humanProtein SubunitsRad30 proteinY-Family DNA Polymerases

Identifiers

PMID25662213
PMCPMC4344513
OpenAlexW2167694443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.